Zoran Culig

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

Medical University of Innsbruck

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Innsbruck Aug 05 1995

Austria

Associate Professor :: Urology

Publications

Chiara Andolfi, Caterina Bartolini, Elisa Morales, Büşra Gündoğdu, Martin Puhr, Juan Guzman, Sven Wach, Helge Taubert, Achim Aigner, Iris E Eder, Florian Handle, Zoran Culig
MED12 and CDK8/19 modulate androgen receptor activity and enzalutamide response in prostate cancer. Endocrinology (2024)
Andrea Eigentler, Florian Handle, Silvia Schanung, Antonia Degen, Hubert Hackl, Holger H H Erb, Georgios Fotakis, Julia Hoefer, Christian Ploner, Karin Jöhrer, Isabel Heidegger, Andreas Pircher, Werner Klotz, Manfred Herold, Georg Schäfer, Zoran Culig, Martin Puhr
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts. Oncogene (2023)
Gennadi Tulchiner, Andrea Brunner, Manuela Schmidinger, Nina Staudacher, Jacob J Orme, Martin Thurnher, Wolfgang Horninger, Zoran Culig, Renate Pichler
CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma. BJU international 128 (1) (2021)
Stanislav Drápela, Prashant Khirsariya, Thomas A Kirkland, Radek Fedr, Tereza Suchánková, Diana Búzová, Jan Cerveny, Aleš Hampl, Martin Puhr, William R Watson, Zoran Culig, Lumír Krejčí, Kamil Paruch, Karel Souček
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe. Molecular oncology 14 (10) (2020)
Martina Gruber, Florian Handle, Zoran Culig
The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells. The Prostate 80 (3) (2019)
Zoran Culig
The way towards understanding possible multiple functions of AR V7 in prostate cancer. BJU international 122 (2) (2019)

Zoran Culig.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zoran Culig